272 related articles for article (PubMed ID: 2867564)
1. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Klemm WR
Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
[TBL] [Abstract][Full Text] [Related]
2. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
Kendler KS; Bracha HS; Davis KL
Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the dopamine depressor response by molindone, a newly introduced neuroleptic.
Nandal NV; Mane VR; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1980; 24(2):143-7. PubMed ID: 6103868
[TBL] [Abstract][Full Text] [Related]
4. D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Klemm WR; Block H
Pharmacol Biochem Behav; 1988 Feb; 29(2):223-9. PubMed ID: 3283778
[TBL] [Abstract][Full Text] [Related]
5. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
6. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.
Undie AS; Friedman E
Psychopharmacology (Berl); 1988; 96(3):311-6. PubMed ID: 2906152
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
8. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
9. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
10. Catalepsy induced by SCH 23390 in rats.
Morelli M; Di Chiara G
Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
[TBL] [Abstract][Full Text] [Related]
11. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
Ossowska K; Karcz M; Wardas J; Wolfarth S
Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
[TBL] [Abstract][Full Text] [Related]
12. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
15. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
16. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
Erzin-Waters C; Muller P; Seeman P
Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
[TBL] [Abstract][Full Text] [Related]
17. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
Banasikowski TJ; Beninger RJ
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
[TBL] [Abstract][Full Text] [Related]
19. Further evaluation of the tropane analogs of haloperidol.
Sampson D; Bricker B; Zhu XY; Peprah K; Lamango NS; Setola V; Roth BL; Ablordeppey SY
Bioorg Med Chem Lett; 2014 Sep; 24(17):4294-7. PubMed ID: 25070422
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
